Terms: = Prostate cancer AND NTRK3, TRKC, 4916, ENSG00000140538, Q16288, gp145 trkC
18 results:
1. The value of a three-microRNA panel in serum for prostate cancer screening.
Lin S; Sun C; Li R; Lu C; Li X; Wen Z; Ge Z; Chen W; Li Y; Li H; Lai Y
Int J Biol Markers; 2024 Mar; 39(1):70-79. PubMed ID: 37960876
[TBL] [Abstract] [Full Text] [Related]
2. Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements.
Tsai JW; Lee JC; Hsieh TH; Huang SC; Lee PH; Liu TT; Kao YC; Chang CD; Weng TF; Li CF; Lin JC; Liang CW; Su YL; Chang IY; Wang YT; Chang NY; Yu SC; Wang JC; Huang HY
Mod Pathol; 2022 Jul; 35(7):911-921. PubMed ID: 35149769
[TBL] [Abstract] [Full Text] [Related]
3. Synthesis, anticancer and antimicrobial evaluation of new benzofuran based derivatives: PI3K inhibition, quorum sensing and molecular modeling study.
El-Khouly OA; Henen MA; El-Sayed MA; Shabaan MI; El-Messery SM
Bioorg Med Chem; 2021 Feb; 31():115976. PubMed ID: 33388654
[TBL] [Abstract] [Full Text] [Related]
4. Neurotrophin Trk Receptors: New Targets for cancer Therapy.
Meldolesi J
Rev Physiol Biochem Pharmacol; 2018; 174():67-79. PubMed ID: 28884193
[TBL] [Abstract] [Full Text] [Related]
5. Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials.
Roviello G; Sigala S; Danesi R; Re MD; Bonetta A; Cappelletti MR; Zanotti L; Bottini A; Generali D
Crit Rev Oncol Hematol; 2016 May; 101():12-20. PubMed ID: 26971992
[TBL] [Abstract] [Full Text] [Related]
6. Androgenetic alopecia and risk of prostate cancer: a systematic review and meta-analysis.
Amoretti A; Laydner H; Bergfeld W
J Am Acad Dermatol; 2013 Jun; 68(6):937-43. PubMed ID: 23395589
[TBL] [Abstract] [Full Text] [Related]
7. Morphologic features of carcinomas with recurrent gene fusions.
Qi M; Li Y; Liu J; Yang X; Wang L; Zhou Z; Han B
Adv Anat Pathol; 2012 Nov; 19(6):417-24. PubMed ID: 23060067
[TBL] [Abstract] [Full Text] [Related]
8. A possible role of BDNF in prostate cancer detection.
Bronzetti E; Artico M; Forte F; Pagliarella G; Felici LM; D'Ambrosio A; Vespasiani G; Bronzetti B
Oncol Rep; 2008 Apr; 19(4):969-74. PubMed ID: 18357383
[TBL] [Abstract] [Full Text] [Related]
9. In vitro and in vivo effects of bicalutamide on the expression of TrkA and P75 neurotrophin receptors in prostate carcinoma.
Festuccia C; Gravina GL; Muzi P; Pomante R; Ventura L; Ricevuto E; Vicentini C; Bologna M
Prostate; 2007 Sep; 67(12):1255-64. PubMed ID: 17596848
[TBL] [Abstract] [Full Text] [Related]
10. Recurrent fusion oncogenes in carcinomas.
Teixeira MR
Crit Rev Oncog; 2006 Dec; 12(3-4):257-71. PubMed ID: 17425505
[TBL] [Abstract] [Full Text] [Related]
11. Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro.
Festuccia C; Muzi P; Gravina GL; Millimaggi D; Speca S; Dolo V; Ricevuto E; Vicentini C; Bologna M
Int J Oncol; 2007 Jan; 30(1):193-200. PubMed ID: 17143529
[TBL] [Abstract] [Full Text] [Related]
12. A fluorescence in situ hybridization study of ETV6-ntrk3 fusion gene in secretory breast carcinoma.
Makretsov N; He M; Hayes M; Chia S; Horsman DE; Sorensen PH; Huntsman DG
Genes Chromosomes Cancer; 2004 Jun; 40(2):152-7. PubMed ID: 15101049
[TBL] [Abstract] [Full Text] [Related]
13. Cytogenetic findings in a case of nodular fasciitis of subclavicular region.
Velagaleti GV; Tapper JK; Panova NE; Miettinen M; Gatalica Z
Cancer Genet Cytogenet; 2003 Mar; 141(2):160-3. PubMed ID: 12606136
[TBL] [Abstract] [Full Text] [Related]
14. Autocrine expression of neurotrophins and their receptors in prostate cancer.
Satoh F; Mimata H; Nomura T; Fujita Y; Shin T; Sakamoto S; Hamada Y; Nomura Y
Int J Urol; 2001 Jul; 8(7):S28-34. PubMed ID: 11442674
[TBL] [Abstract] [Full Text] [Related]
15. More 'malignant' than cancer? Five-year survival following a first admission for heart failure.
Stewart S; MacIntyre K; Hole DJ; Capewell S; McMurray JJ
Eur J Heart Fail; 2001 Jun; 3(3):315-22. PubMed ID: 11378002
[TBL] [Abstract] [Full Text] [Related]
16. Role of neurotrophins and neurotrophins receptors in the in vitro invasion and heparanase production of human prostate cancer cells.
Walch ET; Marchetti D
Clin Exp Metastasis; 1999 Jun; 17(4):307-14. PubMed ID: 10545017
[TBL] [Abstract] [Full Text] [Related]
17. Expression of p75(LNGFR) and Trk neurotrophin receptors in normal and neoplastic human prostate.
Guate JL; Fernández N; Lanzas JM; Escaf S; Vega JA
BJU Int; 1999 Sep; 84(4):495-502. PubMed ID: 10468769
[TBL] [Abstract] [Full Text] [Related]
18. Molecular characterization of neurotrophin expression and the corresponding tropomyosin receptor kinases (trks) in epithelial and stromal cells of the human prostate.
Dalal R; Djakiew D
Mol Cell Endocrinol; 1997 Oct; 134(1):15-22. PubMed ID: 9406845
[TBL] [Abstract] [Full Text] [Related]
